Emily M. Leproust - Oct 21, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
President & CEO, Director
Signature
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
Stock symbol
TWST
Transactions as of
Oct 21, 2021
Transactions value $
-$309,705
Form type
4
Date filed
10/25/2021, 05:01 PM
Previous filing
Oct 19, 2021
Next filing
Nov 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $10.4K +1.74K +1.01% $5.95 174K Oct 21, 2021 Direct
transaction TWST Common Stock Sale -$164K -1.36K -0.78% $120.62* 173K Oct 21, 2021 Direct F1, F2
transaction TWST Common Stock Sale -$46.4K -382 -0.22% $121.36* 172K Oct 21, 2021 Direct F1, F3
transaction TWST Common Stock Tax liability -$110K -936 -0.54% $117.41* 172K Oct 22, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1.74K -2.89% $0.00 58.5K Oct 21, 2021 Common Stock 1.74K $5.95 Direct F8
holding TWST Employee Stock Option (right to buy) 267K Oct 21, 2021 Common Stock 0 $26.66 Direct F5
holding TWST Employee Stock Option (right to buy) 131K Oct 21, 2021 Common Stock 0 $23.33 Direct F6
holding TWST Employee Stock Option (right to buy) 187K Oct 21, 2021 Common Stock 0 $8.82 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $120.235 to $120.93 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $121.305 to $121.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e)
F5 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F8 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.